Watch this webinar from Concept Life Sciences, hosted by Dr. Thomas Pesnot (Concept Life Sciences) and featuring Dr. Rob Riley as keynote speaker, on the ADMET Toolkit for clinical pharmacokinetics.
In this webinar, the speakers will cover:
- What is ADMET and why is it critical to drug discovery?
- Why is (predicted) human PK and exposure so key to success?
- What are the key ADMET challenges?
- How to design a fit-for-purpose screening cascade?
- How to anticipate/identify ADMET challenges and develop adapted solutions?
Presenters
ADME & DMPK Expert
Independent
Dr. Rob Riley is a highly motivated, seasoned science, project, and people leader, and proven drug hunter with >30 years experience in Biopharmaceutical Research & Development in the major therapeutic areas.
Drug Discovery Services Director
Concept Life Sciences
Thomas (Tom) Pesnot, PhD is Drug Discovery Services Director at Concept Life Sciences since 2024. He has gained over 15 years' experience of leading drug discovery programmes in the academic, biotech, and CRO sectors, and contributed to the development of multiple clinical candidates and marketed drugs.
Webinar Host
Concept Life Sciences
Concept Life Sciences is a UK-based drug discovery CRO, helping global pharma and biotech companies accelerate their drug candidate to clinic by offering integrated drug discovery programs.
Additional Content From Concept Life Sciences
Translational Success in Inflammasome Drug Discovery: How Advanced Models and Integrated Assays Can Reduce Attrition
Join Professor Luke O’Neill (Trinity College Dublin) and Dr Elise Malavasi ( Associate Director of Neurosciences Concept Life Sciences) for this webinar that explores recent advances in inflammasome science, and highlights how selecting appropriate in vitro models and meaningful readouts is essential for accurately assessing therapeutic potential.
Uniting biology and digital drug discovery to identify new therapeutic opportunities in neurodegeneration
As the FDA and NIH encourage a shift away from animal testing, there’s growing momentum behind New Approach Methodologies (NAMs) — from advanced in vitro models to computational platforms. In this webinar, Concept Life Sciences and Delta4 present a powerful example of what this future looks like in practice.
Empowering Drug Hunters with High-Throughput Protein Crystallography
Watch this webinar by Concept Life Sciences, hosted by Dr. Thomas Pesnot (Concept Life Sciences) and featuring Dr. Debanu Das from Accelero Biostructure, Inc as keynote speaker.
Related Content
How to Avoid Expensive Redesign Cycles in Antibody Discovery
Learn how integrated antibody discovery and engineering strategies can accelerate the path from hit to optimized lead in less than 12 months while minimizing costly redesign cycles.
Beyond Exposure: Integrating PK/PD for Translational Predictive Power
Learn to integrate PK/PD modeling and strategic biomarkers to bridge the translational gap. Improve clinical predictability for NCEs, ADCs, and large molecules in this technical webinar.
Advancing the Manufacture of Mesenchymal Stromal Cells and Derived Extracellular Vesicles in Stirred-Tank Bioreactors Through Enhanced Bioprocess Control
Learn how to scale the production of MSCs and extracellular vesicles using bioreactor control and real-time monitoring for more consistent therapies.